Norwood — Today, during an event at Moderna's clinical manufacturing facility in Norwood, the Healey-Driscoll Administration and Massachusetts Life Sciences Center (MLSC) announced $24.4 million in tax incentive awards to 43 life sciences companies. The awards, provided through the MLSC's Tax Incentive Program, are expected to create 1,584 new life sciences industry jobs in the Commonwealth.

The MLSC Tax Incentive program is offered to companies engaged in life sciences research and development, commercialization, and manufacturing in Massachusetts, providing incentives to companies of all sizes looking to expand their efforts by creating new, long-term jobs in the state.

"Massachusetts is a global leader in the life sciences sector thanks to companies like Moderna and the dozens of others that will benefit from these tax incentive awards," said Governor Maura Healey. "This funding will support cutting-edge research, advance the manufacturing of life-changing therapies, create thousands of jobs for companies across the state, and strengthen our position as the best place in the world to grow a life sciences company."

"Our administration works every day to help companies start, grow, and stay here in Massachusetts," said Economic Development Secretary Yvonne Hao, who also serves as co-chair of the MLSC Board of Directors. "We are excited to see how today's investments help life sciences companies expand their operations across the state and are grateful to Governor Healey and Lt. Governor Driscoll for their commitment to lengthening our lead as a life sciences hub through this funding."

Out of the 43 companies receiving tax incentive awards, 26 companies—accounting for 69 percent of the new jobs—are expanding outside of Boston and Cambridge. Since the MLSC's reauthorization in 2018, 78 percent of jobs committed through the MLSC's Tax Incentive program are located outside of Boston and Cambridge. Since the Center's inception, life sciences companies expanding across Massachusetts have committed to the creation of more than 11,000 jobs through this program.

"The Life Sciences Center will continue to deploy every resource necessary to support life science companies of all sizes and sub-sectors," said MLSC President and CEO Kenn Turner. "I am grateful for the support of the Healey Administration and legislative leaders who understand the power of public-private partnership to drive economic and workforce development. I am equally excited for the growth of our companies being celebrated today as they work to produce life-saving therapies and products for patients on a global scale."

This year's Tax Incentive Program award recipients represent a diverse cohort of companies working on drug discovery and development, medical devices, diagnostics, and manufacturing. The recipients include:

Scroll left

Scroll right

Company	Expansion Location	Incentive Amount	Jobs Commitment
Access Vascular Inc.	Billerica	$180,000	12
Aera Therapeutics Inc.	Boston	$450,000	30
More on Boston Chron Sidow Sobrino Announces 12th Album, "Seminal" Boston Public Health Commission Encourages People to Get the Flu Shot Ahead of Flu Season Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA) Heartland Soccer Association and VidSport Launch Groundbreaking Live Streaming Service at Garmin Olathe Soccer Complex Massachusetts Wins Proposal to Host Northeast Microelectronics Hub through Federal CHIPS and Science Act Affini-T Therapeutics Inc.	Watertown	$375,000	25
Agilent Technologies Inc.	Chicopee	$150,000	10
Ascidian Therapeutics Inc.	Boston	$180,000	12
Berkshire Sterile Manufacturing	Lee	$225,000	15
Bristol-Myers Squibb Company	Boston/Devens	$1,155,000	77
Charles River Laboratories Inc.	Wilmington	$1,470,000	98
Corner Therapeutics Inc.	Watertown	$150,000	10
Day Zero Diagnostics Inc.	Boston	$225,000	15
Disc Medicine Inc.	Watertown	$150,000	10
ElevateBio Technologies Inc.	Waltham	$600,000	40
Eli Lilly and Company	Boston	$494,000	26
Enanta Pharmaceuticals Inc.	Watertown	$150,000	10
Entegris Inc.	Billerica	$750,000	50
Instrumentation Laboratory Company	Bedford	$255,000	17
Intellia Therapeutics	Cambridge	$1,275,000	85
Lonza Biologics Inc.	Cambridge	$165,000	11
Lyra Therapeutics Inc.	Watertown	$300,000	20
Manifold Bio	Boston	$150,000	10
Matchpoint Therapeutics Inc.	Cambridge	$165,000	11
Mersana Therapeutics Inc.	Cambridge	$150,000	10
Miltenyi Biotec Inc.	Cambridge	$195,000	13
ModernaTX Inc.	Norwood	$3,135,000	209
ModeX Therapeutics Inc.	Natick	$525,000	35
MOMA Therapeutics Inc.	Cambridge	$195,000	13
Nova Biomedical Corporation	Waltham	$1,125,000	75
Optikos Corporation	Wakefield	$180,000	12
PGN US Holding, Inc. and Subsidiaries	Burlington	$150,000	10
Prime Medicine Inc.	Boston	$750,000	50
Rentschler BioPharma Inc.	Milford	$825,000	55
Sarepta Therapeutics Inc.	Cambridge	$1,500,000	100
Seismic Therapeutic Inc.	Cambridge	$150,000	10
Snapdragon Chemistry Inc.	Waltham	$150,000	10
Strand Therapeutics	Boston	$600,000	40
Takeda Pharmaceuticals America Inc.	Lexington	$1,875,000	125
Tessera Therapeutics, Inc.	Sommerville	$1,125,000	75
Tome Biosciences Inc.	Watertown	$750,000	50
Treeline Biosciences Inc.	Watertown	$225,000	15
More on Boston Chron Boston: Art, Space, Community Massachusetts: Governor Healey Celebrates Climate Week by Establishing Nation's First Long-term Biodiversity Goals, Single-Use Plastic Bottle Ban Maryland Sedation Dentistry and Surgical Center Opens in Frederick Maryland LokiBots is one of the 35 early-stage Generative AI startups selected for AWS ML Elevate program 2023 cohort Mil-Spec Safety & Security Launches New Website Trelleborg Sealing Solutions US Inc.	Northborough	$150,000	10
Vaxess Technologies Inc.	Cambridge	$270,000	18
Vedanta Biosciences	Cambridge	$450,000	30
WuXi Biologics USA LLC	Worcester	$1,000,000	25

The MLSC jointly administers the Tax Incentive Program with the Massachusetts Department of Revenue (DOR), which oversees the technical administration of the incentives. Awardees are required to maintain job commitments over a five-year period. The program includes regular reporting requirements for awardees to document jobs created as a result of the incentive. MLSC has continued to use the Tax Incentive Program to leverage diverse life sciences assets across Massachusetts and encourage growth and expansion on a statewide basis.

About the Massachusetts Life Sciences Center

The Massachusetts Life Science Center (MLSC) is an economic development investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts, home to the most verdant and productive life sciences ecosystem in the world. Through public-private funding initiatives, the MLSC supports innovation, research and development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics and digital health. Since its creation in 2007, the MLSC has strategically deployed more than $900 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives and workforce programs. These investments have created thousands of jobs and propelled the development of new therapies, devices and scientific advancements that are improving patient health and well-being in Massachusetts and beyond.

---

Show All News | Report Violation